...a pharma assistance program, and a navigator that connects providers, field teams, and patient support managers. Redi’s most convincing stats are that Traditional Patient Support Programs (PSPs) contribute to a non-adherence rate of approximately 70%, leading to estimated losses of over $600 billion annually for the pharmaceutical industry, but don’t get into the cost of non-adherence in patient outcomes: morbidity and mortality associated with poor medication adherence costs $528.4 billion annually (PAN Foundation). Yahoo!Finance, Mobihealthnews Hat tip to Steven Wardell of Wardell Advisors Another sign of the times? Complicated Deals. DarioHealth is buying Twill, formerly known as Happify (and with... Continue Reading
Search Results for 💖➳♦ Kamagra 100mg - sildenafil citrate samples ↪ ️ www.USPharm.ORG ❦ ↞. pharma without prescription🖤:Kamagra 100mg Sildenafil Citrate - Quality Generic Drugs Cmu, oral jelly 100mg kamagra untuk apa,sildenafil citrate tablets vs viagra,kamagra 100mg for sale,kamagra 50mg,sildenafil citrate 100mg prices india
Roundup: Walgreens’ new chief legal officer; Digital Health Collaborative launched; fundings/M&A defrosting for b.well, R1 RCM, Abridge, Reveleer; Veradigm likely delists, buys ScienceIO–mystery? (updated)
...for Health Outcomes Measurement (ICHOM), National Alliance of Healthcare Purchaser Coalitions, The National Committee for Quality Assurance (NCQA), and RockHealth.org. The DHC with support from PHTI has established a Research and Impact Fund for aligned research and programs. The first grant was provided to DiMe for its Integrated Evidence Plans for Digital Health Products. While a fine list, this Editor notes no payers or hospitals (end user groups) or cybersecurity organizations to advocate for digital health security. DHC release Some funding and M&A action…zounds! b.well Connected Health’s Series C clocks in at $40 million. Leavitt Equity Partners led the raise... Continue Reading
Mid-week roundup: Cotiviti’s $10.5B stake to KKR; Cigna buys back $3.2B shares; VA Oracle Cerner faulty med records; LockBit ransomware websites cold-busted at every level, principals indicted; Trualta partners with PointClickCare
Investor KKR announced their buy of a $10.5 billion stake in healthcare analytics Cotiviti. The stake comes from Veritas Capital, creating an equal share of ownership. The recapitalization will be used for commercial expansion, new product development, and technology-related opportunities. It is expected to close subject to regulatory approvals in Q2 this year. According to Axios and Bloomberg, it is financed by a $5 billion leveraged loan sale launched last week, with a $4.4 billion floating rate term loan led by JPM and a $600 million fixed rate term loan led by Goldman Sachs. This is Veritas’ second attempt to... Continue Reading
Weekend reading: why the tech experience for older adults needs a reboot (a boot in the….?), health tech takeaways from CES
Your Editor wants to wrap the week on a positive note. There can be too much ‘facing the music’ and not all the tunes apply to us personally, nor if they’re playing, can we turn them off. But Laurie Orlov in her always-thoughtful Aging and Health Technology Watch (formerly ‘Aging In Place Technology Watch’) draws our professional attention to the nagging question of design and the user experience for older adults, even the ones who used computers with black screens in the 1980s, Palm Pilots, Crackberries, and feature phones. While older adults have adopted smartphones, tablets, and smartwatches, they’ve felt... Continue Reading
Further confirmation of the New Reality for digital health–lower valuations, more exits, fewer startups, tech buyers not seeing ROI
...surrounding digital health/health technology. More exits of various types, reduced valuations, need to fundraise again among digital health startups. Katie Adams of MedCityNews, which of the mainstream online health news websites has the tartest takes on the business, interviewed two investors in digital health. Their POVs: Cheryl Cheng, CEO of Vive Collective (Menlo Park, California) Raised large rounds in 2021? These companies now face ‘valuation overhangs’ that aren’t ‘bridged by organic growth’ and a far tighter investment environment with reduced valuations and exits. (That exit may be a sale–or a shutdown–Ed.) Investor priority? Profitability, not growth. What counts in today’s... Continue Reading
Facing the Music of the New Reality: Amazon Pharmacy & One Medical restructure; Walgreens shakes up health exec suites again, cashes out $992M in Cencora; new takes on NeueHealth; Cue Health, Nomad Health layoffs
...Moving to an advisor position is the current president, John Driscoll. US Healthcare includes VillageMD, Summit Health/CityMD and CareCentrix. In addition, Manmohan Mahajan was appointed as permanent CFO, having held the position on an interim basis from July. Elizabeth Burger was named as EVP and chief HR officer from a similar position at industrial Flowserve, replacing Holly May who departed in November and is now with Petco. Crain’s Chicago Business, FierceHealthcare Slipping under this was a further sale of Walgreens’ position in Cencora, the former AmerisourceBergen, a highly diversified pharmaceutical distributor. The sale of approximately $942 million of Cencora common... Continue Reading
News roundup: Cano Health files Ch. 11 bankruptcy, delisted (updated), Walgreens lays off more, Allina Health outsources 2,000 RCM jobs to Optum
...by the RSA conversion, is that common shareholders–probably including the infamous Cano 3 who owned about 35% of the shares–will receive bupkis, nada, zip, zero in the reorganization. Update: The NYSE delisted Cano Health’s (CANO) stock late on Monday, citing the RSA conversion. Press release, Healthcare Dive. The Class A shares are now listed OTC (the ‘pink sheets’) under CANOQ at $0.70. Shareholders are wholesale unloading with the day’s volume over 580,000 compared to the previous average of 340,000 shares. Cano remains for sale during this process according to the release. Here’s the 36-page filing, courtesy of Industry Dive. Healthcare... Continue Reading
Sell NHS medical records to fund AI, biotech? Not quite what’s in the Blair-Hague report. (updated)
...#2 is the point making the headlines in the Independent and Sky News. The reports do not explain that the sale of the NHS medical records would be done through the NHSDT. It would negotiate data-sharing agreements with external organizations and be capable of joining profit-sharing arrangements, while guarding that data would not be sold to third parties and be strictly anonymized. The plain language of the recommendation: “Provide research entities with access to the anonymised data in return for financial profit, which would benefit the NHS. This could happen via a range of mechanisms, varying from direct financial payment... Continue Reading
23andMe data breach may have targeted those of Jewish and Chinese heritage; company valuation crashes (updated)
...of individuals with information for sale, by 11 January Representative Josh Gottheimer (CD-5, NJ) sent a letter to the director of the FBI to investigate the hacking, specifically because the information could be purchased via sites used by hackers to merch this type of information–and used to target Jews globally. Third-party data included in the hack? There is also the possibility that DNA information from third parties such as Sequencing entered 23andMe’s database. In Illinois and other states, this type of sharing is illegal without specific consent. This information could also have been stolen without the knowledge of the individual.... Continue Reading
News roundup: Musk’s Neuralink implants first human BCI; Cigna’s $3.7B MA sale to HCSC; no Amazon deal for iRobot; DispatchHealth-Instacart food Rx; 5 India health tech fundings (updated)
...what they term a unique combination of online physiotherapy, yoga therapy, and AI. BiospectrumIndia In October, they had raised $1 million from Flipkart Ventures. Times of India Docosage, described as an AI-driven health solutions provider with a telehealth consult, e-prescribing, lab testing, and genetic studies platform, also has an undisclosed amount of pre-seed funding from an individual angel investor. The funding will be used for strategic partnerships by exploring collaborations with hospitals, clinics, insurance companies, and incorporating tech advancements to enhance product features. ExpressHealthcare India *Updated 2 Feb for additional analysis around Cigna MA sale to HCSC and copy editing... Continue Reading
Most Recent Comments